Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population

British Journal of Cancer

Volumn 74, Issue 2, 1996, Pages 288-290

  Maynadie M ^a   Verret, C ^a   Moskovtchenko, P ^a   Mugneret, F ^a   Petrella, T ^a   Caillot, D ^a   Carli, P M ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Incidence rate; Myelodysplastic syndrome; Transformation rate

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; BLAST CELL; CANCER INCIDENCE; CANCER REGISTRY; CANCER SURVIVAL; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SEX RATIO; SURVIVAL RATE;

EID: 0030016365     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.354     Document Type: Article

References (15)

1. AUL C, GATTERMANN N AND SCHNEIDER W. (1992). Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br. J. Haematol., 82, 358-367.
2. BENNETT JM, CATOVSKY D, DANIEL MT, FLANDRIN G, GALTON DAG, GRANILCK HR AND SULTAN C. (1982). Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol., 51, 189-199.
3. CARLI PM, MILAN C, LANGE A, DEVILLIERS E, GUY H AND FAIVRE J. (1986). Haematopoietic malignancies in Côte d'Or (France): a population based study. Br. J. Cancer, 53, 811-815.
4. CARTWRIGHT RA, ALEXANDER FE, MCKINNEY PA AND RICKETTS TJ. (1990). Myelodysplastic states. In Leukemia and Lymphoma. An Atlas of Distribution within Areas of England and Wales (1984-1988). pp. 32-40. Leukemia Research Fund: London.
5. FENAUX P, JOUET JP, ZANDECKI M, LAZI JL, SIMON M, POLLET JP AND BAUTERS F. (1987). Chronic and subacute myelomonocytic leukemia in the adult: a report of 60 cases with special reference to prognostic factors. Br. J. Haematol., 65, 101-106.
6. INSTITUT NATIONAL DE LA STATISTIQUE ET DES ETUDES ECONOMIQUES (INSEE). (1991). Resencement Général de la Population de 1990. INSEE: PARIS.
7. JANSSEN JWG, BUSCHLE M, LAYTON M, DREXLER HG, LYONS J, VAN DEN BERGHE H, HEIMPEL H, KUBANEK B, KLEIHAUER E, MUFTI GJ AND BARTRAM CR. (1989). Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood, 73, 248-254.
8. KERKHOFS H, HERMANS J, HAAK HL AND LEEKSMA CHW. (1987). Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br. J. Haematol., 65, 73-81.
9. LAMBERTENGHI-DELILIERS G, ORAZI A, LUKSCH R, ANNAROLO C AND SOLIGO D. (1991). Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity. Br. J. Haematol., 78, 161-166.
10. MUFTI GJ, STEVENS JR, OSCIER DG, HAMBLIN TJ AND MACHIN D. (1985). Myelodysplastic syndromes: a scoring system with prognostic significance. Br. J. Haematol., 59, 1425-1433.
11. PHILLIPS MJ, CULL GM AND EWINGS M. (1994). Establishing the incidence of myelodysplasia syndrome. Br. J. Haematol., 88, 896-897.
12. REIZENSTEIN P AND DABROWSKI L. (1991). Increasing prevalence of the myelodysplastic syndromes. An international Delphi study. Anticancer Res., 11, 1069-1070.
13. TRICOT G, DE WOLF-PETERS C, HENDRICKX B AND VERWILGHEN RL. (1984). Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br. J. Haematol., 57, 423-430.
14. WILLIAMSON PJ, KRUGER AR, REYNOLDS PJ, HAMBLIN TJ AND OSCIER DG. (1994). Establishing the incidence of myelodysplastic syndrome. Br. J. Haematol., 87, 743-745.
15. WORLD HEALTH ORGANIZATION (WHO). (1977). International Classification of Diseases. 9th revision. World Health Organization: Geneva.